These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Help, hinder, hide and harm: what can we learn from the interactions between Limoli DH; Hoffman LR Thorax; 2019 Jul; 74(7):684-692. PubMed ID: 30777898 [TBL] [Abstract][Full Text] [Related]
9. Microbial ecology and adaptation in cystic fibrosis airways. Yang L; Jelsbak L; Molin S Environ Microbiol; 2011 Jul; 13(7):1682-9. PubMed ID: 21429065 [TBL] [Abstract][Full Text] [Related]
10. The cystic fibrosis lung microbiome. Surette MG Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S61-5. PubMed ID: 24437409 [TBL] [Abstract][Full Text] [Related]
11. Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa. Petersen NT; Høiby N; Mordhorst CH; Lind K; Flensborg EW; Bruun B Acta Paediatr Scand; 1981 Sep; 70(5):623-8. PubMed ID: 6798822 [TBL] [Abstract][Full Text] [Related]
12. Strategies of Pseudomonas aeruginosa to colonize and to persist in the cystic fibrosis lung. Kubesch P; Lingner M; Grothues D; Wehsling M; Tümmler B Scand J Gastroenterol Suppl; 1988; 143():77-80. PubMed ID: 3133755 [TBL] [Abstract][Full Text] [Related]
13. Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis. Aanæs K J Cyst Fibros; 2013 Sep; 12 Suppl 2():S1-20. PubMed ID: 24064077 [TBL] [Abstract][Full Text] [Related]
14. Harnessing Neutrophil Survival Mechanisms during Chronic Infection by Marteyn BS; Burgel PR; Meijer L; Witko-Sarsat V Front Cell Infect Microbiol; 2017; 7():243. PubMed ID: 28713772 [TBL] [Abstract][Full Text] [Related]
15. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa. Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB mBio; 2020 Jun; 11(3):. PubMed ID: 32576671 [No Abstract] [Full Text] [Related]
16. Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis. McIsaac SM; Stadnyk AW; Lin TJ J Leukoc Biol; 2012 Nov; 92(5):977-85. PubMed ID: 22892106 [TBL] [Abstract][Full Text] [Related]
17. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis. Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639 [TBL] [Abstract][Full Text] [Related]
18. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors. West SE; Zeng L; Lee BL; Kosorok MR; Laxova A; Rock MJ; Splaingard MJ; Farrell PM JAMA; 2002 Jun; 287(22):2958-67. PubMed ID: 12052125 [TBL] [Abstract][Full Text] [Related]
19. Pseudomonas aeruginosa Volatilome Characteristics and Adaptations in Chronic Cystic Fibrosis Lung Infections. Davis TJ; Karanjia AV; Bhebhe CN; West SB; Richardson M; Bean HD mSphere; 2020 Oct; 5(5):. PubMed ID: 33028687 [No Abstract] [Full Text] [Related]
20. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way? Banerjee D; Stableforth D Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]